Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial
Patients with type 2 diabetes with high UACR, or with low UACR and low TG, but high predicted cardiovascular risk and long diabetes duration were likely to derive cognitive benefits from intensive BP treatment.
Authors
- Yufang Bi (ORCID: https://orcid.org/0000-0002-4829-5915)
- Jieli Lu (ORCID: https://orcid.org/0000-0003-1317-0896)
- Xiaoli Xu (ORCID: https://orcid.org/0000-0003-2891-4800)
- Siyu Wang (ORCID: https://orcid.org/0000-0003-2126-0306)
- Yu Xu (ORCID: https://orcid.org/0000-0003-1045-8309)
- Zhiyun Zhao (ORCID: https://orcid.org/0000-0001-5950-2732)
- Ruizhi Zheng (ORCID: https://orcid.org/0000-0002-2068-7597)
- Tiange Wang (ORCID: https://orcid.org/0000-0003-0723-489X)
- Jie Zheng (ORCID: https://orcid.org/0000-0002-6623-6839)
- Xiang Yu (ORCID: https://orcid.org/0000-0002-9005-3733)
- Xuan Zhao (ORCID: https://orcid.org/0000-0003-0119-7768)
- Kan Wang (ORCID: https://orcid.org/0000-0001-9811-4142)
- Xiaoyun Zhang (ORCID: https://orcid.org/0000-0002-6239-9569)
- Mian Li (ORCID: https://orcid.org/0000-0001-6514-2729)
- Min Xu (ORCID: https://orcid.org/0000-0003-3930-8718)
Institutions
- Ruijin Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1111/dom.16145
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Shanghai Clinical Research Center